oxybutynin has been researched along with sirolimus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Maciejewski, CC; Metcalfe, PD; Tredget, EE | 1 |
| Kumar, MNK; Wu, MX; Zhou, C | 1 |
1 review(s) available for oxybutynin and sirolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for oxybutynin and sirolimus
| Article | Year |
|---|---|
Urodynamic improvements following oral medical therapy for partial bladder outlet obstruction in an animal model.
Topics: Administration, Oral; Animals; Carbolines; Disease Models, Animal; Female; Mandelic Acids; Muscarinic Antagonists; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Sirolimus; Tadalafil; Urinary Bladder Neck Obstruction; Urodynamics | 2015 |
Laser-facilitated epicutaneous immunotherapy to IgE-mediated allergy.
Topics: Administration, Cutaneous; Allergens; Animals; Calcitriol; Cytokines; Desensitization, Immunologic; Female; Immunoglobulin E; Immunoglobulin G; Lasers; Lung; Mice, Inbred BALB C; Oligodeoxyribonucleotides; Ovalbumin; Powders; Respiratory Hypersensitivity; Sirolimus; Skin; T-Lymphocytes, Regulatory; Transdermal Patch | 2016 |